ArticleThe British journal of general practice : the journal of the Royal College of General Practitioners1995
General practitioners' tacit and stated policies in the prescription of lipid lowering agents.
Article in The British journal of general practice : the journal of the Royal College of General Practitioners, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 48 citations in OpenAlex.
- Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer.British journal of cancer · 2017Article
- De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancer.British journal of cancer · 2016Article
- Statin Use Reduces Prostate Cancer All-Cause Mortality: A Nationwide Population-Based Cohort Study.Medicine · 2015Observational
- Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.Diabetic medicine : a journal of the British Diabetic Association · 2014Observational
- Statin a day keeps cancer at bay.World journal of clinical oncology · 2013Article
- The role of computerized decision support in reducing errors in selecting medicines for prescription: narrative review.Drug safety · 2011Review
- Evaluation of nurses' self-insight into their pain assessment and treatment decisions.The journal of pain · 2010Article
- Which doctors are influenced by a patient's age? A multi-method study of angina treatment in general practice, cardiology and gerontology.Quality & safety in health care · 2007Article
- Impact of obesity on resource utilization for general surgical procedures.Annals of surgery · 2005Article
- GPs' decisions on drug treatment for patients with high cholesterol values: a think-aloud study.BMC medical informatics and decision making · 2004Article
- A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2003Article
- Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.Heart (British Cardiac Society) · 1999Article
- A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients.The British journal of general practice : the journal of the Royal College of General Practitioners · 1996Article
- What constitutes controlled hypertension? Patient based comparison of hypertension guidelines.BMJ (Clinical research ed.) · 1996Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResearch into general practitioners' prescribing behaviour with regard to lipid lowering agents has relied on survey methods which presume that doctors have insight into their prescribing behaviour and can describe it accurately.
aimThis study set out to measure the tacit policies used by general practitioners in prescribing lipid lowering agents and to compare these with their stated policies.
methodEffects of 13 separate cues on decisions to prescribe were examined. The cues included cholesterol levels and a number of associated risk factors for coronary heart disease. Doctors rated 130 imaginary cases presented by a computer. Thirty five general practitioners in the Plymouth area participated in the study. Their ages ranged from 31 to 55 years and all but four were men. The raw data in each case was a rating of the likelihood that the doctor would prescribe for the patient described. These were converted into statistical weightings by use of multiple linear regression. The pattern of (standardized) weights constituted the tacit policy for each doctor. Stated policies were measured in a subsequent interview by asking doctors to rate the influence of each cue.
resultsBoth tacit and stated policies diverged widely between different doctors. Most doctors overestimated the number of cues that had actually influenced their decisions, and many believed that they had taken into account associated factors for coronary heart disease when they had not. On lifestyle related risks doctors were generally less likely to treat overweight people and most stated this as their policy. Most were also less likely to treat smokers but some had the opposite policy. Those less likely to treat smokers were also less likely to treat obese patients. There was also considerable variation in the extent to which the doctors took account of the attitude of the patient to receiving treatment.
conclusionDoctors' policies are highly variable and particularly inconsistent in the treatment of smokers. Relevant risk factors may be ignored--even though they are understood--because the risk assessment involved is too psychologically complex a task to be performed intuitively. Decision aids and clear protocols are needed in this area.
Indexed as
Identifiers
7779468PMC1239107W157592648What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.